Pure Global
NCT05354934

Study of Entry and Continuation in Care for People Living With HIV in French Guiana

Centre Hospitalier de Cayenne·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Human Immunodeficiency Virus
Drug/Device/Intervention
quetionnaire
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Centre Hospitalier de Cayenne
Location
Cayenne, French Guiana
Timeline & enrollment
Phase
N/A
Start date
Mar 23, 2022
End date
Jun 23, 2023
Enrollment
300 participants
Primary outcome

Identifying factors associated with loss of sight for more than 12 months among people living with HIV in Guyana

Summary

Research Involving the Non-Interventional Human Subject (RIPH category 3).
 Non-interventional, cross-sectional, multicentre, descriptive and analytical epidemiological
 study.
 
 A cross-sectional, pseudo-anonymous questionnaire focusing on entry and retention in care
 will be administered to a sample of PLHIV presenting for consultation in one of the GHT
 hospitals over a 12-month period.
 
 A sample of 300 PHAs is envisaged to have sufficient power to highlight the main factors
 associated with periods of loss of sight.
 
 Main objective:
 
 - To identify factors associated with loss of sight for more than 12 months among people
 living with HIV in Guyana
 
 Secondary objectives:
 
 - To identify factors associated with a delay in the introduction of ARVs among PLHIV in
 Guyana
 
 - To describe the perception of the quality of the announcement of the diagnosis of HIV
 
 - To describe the difficulties encountered by PLHIV during their hospital follow-up in
 French Guyana
 
 - To assess the perceived stigma associated with HIV and its consequences in daily life

ICD-10 classifications
Human immunodeficiency virus [HIV] diseaseUnspecified human immunodeficiency virus [HIV] diseaseHuman immunodeficiency virus [HIV] disease resulting in other conditionsHuman immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseasesAsymptomatic human immunodeficiency virus [HIV] infection status
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05354934
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05354934 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier de Cayenne and is currently Recruiting. The study focuses on Human Immunodeficiency Virus. Target enrollment is 300 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.